Intervention at the earliest illness stage, in ultra or clinical high-risk individuals, or indicated
prevention, currently represents the most promising strategy to ameliorate, delay or prevent …

The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention,
with speculation that CBD can be useful in a wide range of conditions. Only one product, a …

Cannabidiol's (CBD) safety profile and broad action has made it a popular treatment option
for anxiety and co-occurring sleep disturbance. However, its efficacy in healthy and clinical …

Background Cannabidiol (CBD), a major nonintoxicating constituent of cannabis, exhibits
anxiolytic properties in preclinical and human studies and is of interest as a novel …

Background: Cannabidiol (CBD), one of the major cannabinoids derived from the cannabis
plant, is available over the counter. CBD is often used by patients for the management of …

Current silo-based diagnostic systems for mental disorders lack utility and fail to fulfil a
fundamental purpose of diagnosis: to guide treatment planning and predict outcomes …

Background: Anxiety is second most common reason for medicinal cannabis prescription in
Australia and is being treated with both Delta9-tetrahydrocannabinol (THC)-containing and …

Abstract Rationale Delta-9-tetrahydrocannabinol (THC), an active component of cannabis,
can cause anxiety in some users during intoxication. Cannabidiol (CBD), another constituent …

Study Objectives: Low-dose cannabidiol (CBD) has become readily available in numerous
countries; however, little consensus exists on its efficacy as a sleep aid. This trial explored …

Rationale: The slowing of disease progression in dementia in the early stages of diagnosis
is paramount to improving the quality of life for those diagnosed and their support networks …